Efficacy of second generation antidepressants in late-life depression: A meta-analysis of the evidence

American Journal of Geriatric Psychiatry

Volumn 16, Issue 7, 2008, Pages 558-567

  Nelson, J Craig ^a,d   Delucchi, Kevin ^a   Schneider, Lon S ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Box 0984 F ^*  (United States)

Author keywords

Antidepressants; Late life depression; Meta analysis

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; PAROXETINE; PLACEBO; SERTRALINE; VENLAFAXINE;

ARTICLE; ATTRIBUTABLE RISK; CLINICAL EVALUATION; CLINICAL TRIAL; COCHRANE LIBRARY; DEPRESSION; DRUG WITHDRAWAL; EVIDENCE BASED PRACTICE; GERONTOPSYCHIATRY; HUMAN; MAJOR DEPRESSION; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; OUTPATIENT; RANDOMIZED CONTROLLED TRIAL; REMISSION; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; UNITED STATES; UNSPECIFIED SIDE EFFECT; AGED; COMPARATIVE STUDY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; REVIEW; TREATMENT OUTCOME;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER, MAJOR; HUMANS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 50349087007     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/01.JGP.0000308883.64832.ed     Document Type: Article

References (38)

1. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000; 157(suppl 4): 1-45
2. Schneider LS, Olin JT: Efficacy of acute treatment for geriatric depression. Int Psychogeriatr 1995; 7(suppl):7-25
3. Nelson JC: Treatment of major depression in the elderly, in Geriatric Psychopharmacology. Edited by Nelson JC. New York, Marcel Dekker, 1997, pp 61-97
4. Mittmann N, Herrmann N, Einarson TR, et al: The efficacy, safety, and tolerability of antidepressants in late life depression: a meta-analysis. J Affect Disord 1997; 46:191-217
5. Wilson K, Mottram P, Sivanranthan A, et al: Antidepressants versus placebo for the depressed elderly (Cochrane Review). The Cochrane Database for Systematic Reviews 2001, Issue 1. Art number: CD000561. DOI: 10.1002/14651858, CD000561
6. Taylor WD, Doraiswamy PM: A systematic review of antidepres-sant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future. Neuropsychophar-macology 2004; 29:2285-2299
7. Roose SP, Schatzberg AF: The efficacy of antidepressants in the treatment of late life depression. J Clin Psychopharmacol 2005; 25(suppl 1):S1-S7
8. Pinquart M, Duberstein PR, Lyness JM: Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacother-apy and psychotherapy. Am J Psychiatry 2006; 163:1493-1501
9. Tollefson GD, Bosomworth JC, Heiligenstein JH, et al: Fluoxetine Collaborative Group: a double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. Int Psychogeriatrics 1995; 7:89-104
10. Roose SP, Sackeim HA, Krishnan KRR, et al: Antidepressant pharmaco-therapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry 2004; 161:2050-2059
11. Kasper S, de Swart H, Andersen HF: Escitalopram in the treatment of depressed elderly patients. Am J Geriatr Psychiatry 2005; 13:884-891
12. Schneider LS, Nelson JC, Clary CM, et al: An eight-week, multi-center, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry 2003; 160:1277-1285
13. Rapaport MH, Schneider LS, Dunner DL, et al: Efficacy of con-trolled-release paroxetine in the treatment of late-life depression. J Clin Psychiatry 2003; 64:1065-74
14. Raskin J, Wiltse C, Dinkel J, et al: Duloxetine vs placebo in the treatment of elderly patients with major depressive disorder. Presented at the Annual Meeting of the American Association of Geriatric Psychiatry, San Diego, CA, March 3-5, 2005
15. Schatzberg A, Roose S: A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression. Am J Geriatr Psychiatry 2006; 14:361-370
16. Bose A, Saikali KG, Gandhi C, et al: Escitalopram in the acute treatment of depressed patients aged 60 years or older. Presented at the Annual Meeting of the American Association of Geriatric Psychiatry, San Juan, Puerto Rico, March 10-13, 2006
17. Rousseau R, Wrightman D, Hewett K, et al: Efficacy and safety of bupropion XL in elderly patients with major depressive disorder. Presented at the Annual Meeting of the American Psychiatric Association, Toronto, Canada, May 20-25, 2006
18. Pitts CD, Schaefer DM, Lipschitz A, et al: Efficacy and safety of paroxetine CR in the treatment of major depression in the elderly. Presented at the Annual Meeting of the American Psychiatric Association, Atlanta, GA, May 21-26, 2005
19. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17:1-12
20. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry I960; 23:56-61
21. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389
22. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539-1558
23. Deeks J, Altman D, Bradburn M: Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis, in Systematic Reviews in Health Care: Mate-Analysis in Context. Second Ed, Edited by Egger M Davey-Smith G, Altman D. London, BMJ Publication Group, 2001
24. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
25. Mottram P, Wilson K, Strobl J: Antidepressants for depressed elderly. The Cochrane Database of Systematic Reviews 2006; Issue 1. Art. No: CD003491.pub2, DOI: 10.1002/14651858, CD003491.pub2
26. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188
27. Branconnier RJ, Cole JO, Ghazvinian S, et al: Treating the depressed elderly patient: the comparative behavioral pharmacology of mianserin and amitriptyline. Adv Biochem Psychopharmacol 1982; 32:195-212
28. Cohn JB, Varga L, Lyford A: A two-center double-blind, study of nomifensine, imipramine, and placebo in depressed geriatric outpatients. J Clin Psychiatry 1984; 45(pt 2):68-72
29. Merideth CH, Feighner JP, Hendrickson G: A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients. J Clin Psychiatry 1984; 45(pt 2):73-77
30. Wakelin JS: Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data. Int Clin Psychopharmacol 1986; 1:221-230
31. Nair NP, Amin M, Holm P, et al: Moclobemide and nortriptyline in elderly depressed patients. A randomized, multicenter trial against placebo. J Affect Disord 1995; 33:1-9
32. Roth M, Mountjoy CQ, Amrein R: Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial. BrJ Psychiatry 1996; 168:149-157
33. Rampello L, Alvano A, Chiecchio S, et al: An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression. A random, placebo-controlled study. Arch Gerontol Geriatr 2005; 40:275-285
34. Reynolds CF, Dew MA, Pollock B, et al: Maintenance treatment of major depression in old age. N Engl J Med 2006; 354:1130-1138
35. Kornstein SG, Bose A, Li D, et al: Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial. J Clin Psychiatry 2006; 67:1767-1775
36. Turner MS, May DB, Arthur RR, et al: Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks. J Intern Med 2007; 261:205-213
37. Jacob S, Spinier SA: Hyponatremia associated with selective sero-tonin-reuptake inhibitors in older adults. Ann Pharmacother 2006; 40:1618-1622
38. Richards JB, Papaioannou A, Adachi JD, et al: Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 2007; 167:188-194